A Study to Evaluate the Efficacy of Fingolimod to Achieve No Evidence of Disease Activity (NEDA) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)
Latest Information Update: 26 Feb 2016
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 26 Feb 2016 New trial record